Syngene International has incorporated a wholly-owned subsidiary company ‘Syngene Scientific Solutions’ (SSSL) on August 10, 2022. SSSL shall be engaged in Contract Research and Manufacturing Services (CRAMS) and Clinical research services.
Syngene International is India’s largest Contract Research Services Organization providing integrated discovery and development services for novel molecules across multiple platforms including small molecules, large molecules, Antibody-Drug Conjugates and Oligonucleotides.
